Φορτώνει......
A meta-analysis comparing regorafenib with TAS-102 for treating refractory metastatic colorectal cancer
OBJECTIVE: We performed this meta-analysis to compare the efficacy and toxicity of regorafenib and TAS-102. METHODS: Electronic databases were searched to identify studies comparing the efficacy and safety of regorafenib and TAS-102 in patients with chemotherapy-refractory metastatic colorectal canc...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | J Int Med Res |
|---|---|
| Κύριοι συγγραφείς: | , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
SAGE Publications
2020
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7361493/ https://ncbi.nlm.nih.gov/pubmed/32660291 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/0300060520926408 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|